4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Novel integrated strategies for worldwide mycotoxin reduction in the food and feed chains (MycoRed)
Date du début: 1 avr. 2009, Date de fin: 30 sept. 2013,
MYCORED aims at developing strategic solutions to reduce contamination by mycotoxins of major concern in economically important food and feed chains. The following toxins and commodities are especially considered in the project: aflatoxins, trichothecenes, zearalenone, fumonisins in wheat/maize food and feed chains; ochratoxin A in the grape-wine and wheat chains; and aflatoxins in the dried fruit ...
Voir le projet
26
Participants partenaires
TERMINÉ
Access to Pharmaceuticals (ATP)
Date du début: 1 oct. 2009, Date de fin: 31 mars 2013,
Access to Pharmaceuticals Equitable access to pharmaceuticals, particularly for developing countries is an essential human right. Various complex impediments hinder access, which is the subject of ongoing multidisciplinary studies. Intellectual Property and product development are two issues that can be used as tools to address the problem of access, particularly to make patented drugs more afford ...
Voir le projet
5
Participants partenaires
TERMINÉ
EO in Malaria Vector Control and Management (MALAREO)
Date du début: 1 févr. 2011, Date de fin: 31 janv. 2013,
"“In Africa today, malaria is understood to be both a disease of poverty and a cause of poverty."" Nevertheless, malaria is a preventable and curable disease. According to the Abuja declaration, the goal is to halve malaria mortality in Africa by 2010.” (WHO, 2008, Status Report on Malaria in the African region). This report also states that most of the African countries within the region are atte ...
Voir le projet
6
Participants partenaires
TERMINÉ
Novel secretion systems of Mycobacterium tuberculosis and their role in host-pathogen interaction (NOVSEC-TB)
Date du début: 1 janv. 2008, Date de fin: 30 juin 2011,
"Tuberculosis is a major public health threat to the populations of Europe and the world. Mycobacterium tuberculosis, the etiological agent of the disease, can multiply and persist within phagocytic cells and this early event is of primary importance for the outcome of the infection. The main objectives of this proposal are to use highly innovative approaches in molecular and cell biology, biochem ...
Voir le projet